SCHEMBL6601946

SCHEMBL6601946

COC(=O)CCCCCCCCC(=O)Nc1ccc(-n2nc(OC)oc2=O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 1/20 0.57
LIPC P11150 1/20 0.57
LIPE Q05469 1/20 0.57
ABHD16A O95870 1/20 0.51
MGLL Q99685 4/20 0.47
FAAH O00519 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
PTPRC P08575 3/20 0.46
PTPN13 Q12923 1/20 0.46
HDAC8 Q9BY41 3/20 0.45
HDAC3 O15379 2/20 0.44
HDAC4 P56524 2/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC7 Q8WUI4 2/20 0.44
HDAC2 Q92769 2/20 0.44
HDAC10 Q969S8 2/20 0.44
HDAC11 Q96DB2 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
HDAC9 Q9UKV0 2/20 0.44
HDAC5 Q9UQL6 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7043932 0.77 LPL (0.56) LPLLIPCLIPEABHD16AMGLL
SCHEMBL31635262 0.77 L3MBTL1 (0.69) L3MBTL1PTPRCPTPN13HDAC8HDAC3
SCHEMBL7042329 0.76 MGLL (0.61) LPLLIPCLIPEABHD16AMGLL
SCHEMBL7046445 0.73 MGLL (0.62) LPLLIPCLIPEABHD16AMGLL
SCHEMBL7047919 0.72 LPL (1.00) LPLLIPCLIPEABHD16AMGLL
SCHEMBL6600164 0.72 FAAH (0.56) LPLLIPCLIPEMGLLFAAH
SCHEMBL6600553 0.72 LPL (0.62) LPLLIPCLIPEABHD16AMGLL
SCHEMBL13529755 0.71 HDAC8 (0.64) L3MBTL1PTPRCPTPN13HDAC8HDAC3
SCHEMBL6551089 0.71 ABHD16A (0.67) LPLLIPCLIPEABHD16AMGLL
SCHEMBL31054382 0.70 HDAC8 (0.62) L3MBTL1PTPRCPTPN13HDAC8HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263745-B1 SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONE AND USE THEREOF FOR INHIBITING HORMONE-SENSITIVE LIPASE AVENTIS PHARMA GMBH (DE) 2004-05-19 EP disclosed